These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 21701688)

  • 1. The slow-releasing hydrogen sulfide donor, GYY4137, exhibits novel anti-cancer effects in vitro and in vivo.
    Lee ZW; Zhou J; Chen CS; Zhao Y; Tan CH; Li L; Moore PK; Deng LW
    PLoS One; 2011; 6(6):e21077. PubMed ID: 21701688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of fast versus slow-releasing hydrogen sulfide donors in hypertension in pregnancy and fetoplacental growth restriction.
    Zochio GP; Possomato-Vieira JS; Chimini JS; da Silva MLS; Dias-Junior CA
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Dec; 392(12):1561-1568. PubMed ID: 31363805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GYY4137, a hydrogen sulfide (H₂S) donor, shows potent anti-hepatocellular carcinoma activity through blocking the STAT3 pathway.
    Lu S; Gao Y; Huang X; Wang X
    Int J Oncol; 2014 Apr; 44(4):1259-67. PubMed ID: 24535538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydrogen sulfide donors prevent lipopolysaccharide-induced airway hyperreactivity in an in vitro model of chronic inflammation in mice.
    Karaman Y; Kaya-Yasar Y; Bozkurt TE; Sahin-Erdemli I
    Basic Clin Pharmacol Toxicol; 2021 May; 128(5):652-660. PubMed ID: 33369105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of intranasal treatment with slow (GYY4137) and rapid (NaHS) donors of hydrogen sulfide in lipopolysaccharide-induced airway inflammation in mice.
    Kaya-Yasar Y; Karaman Y; Bozkurt TE; Onder SC; Sahin-Erdemli I
    Pulm Pharmacol Ther; 2017 Aug; 45():170-180. PubMed ID: 28645584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GYY4137, a novel hydrogen sulfide-releasing molecule, protects against endotoxic shock in the rat.
    Li L; Salto-Tellez M; Tan CH; Whiteman M; Moore PK
    Free Radic Biol Med; 2009 Jul; 47(1):103-13. PubMed ID: 19375498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a novel, water-soluble hydrogen sulfide-releasing molecule (GYY4137): new insights into the biology of hydrogen sulfide.
    Li L; Whiteman M; Guan YY; Neo KL; Cheng Y; Lee SW; Zhao Y; Baskar R; Tan CH; Moore PK
    Circulation; 2008 May; 117(18):2351-60. PubMed ID: 18443240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological Effects of Morpholin-4-Ium 4 Methoxyphenyl (Morpholino) Phosphinodithioate and Other Phosphorothioate-Based Hydrogen Sulfide Donors.
    Nin DS; Idres SB; Song ZJ; Moore PK; Deng LW
    Antioxid Redox Signal; 2020 Jan; 32(2):145-158. PubMed ID: 31642346
    [No Abstract]   [Full Text] [Related]  

  • 9. GYY4137, a novel water-soluble, H2S-releasing molecule.
    Rose P; Dymock BW; Moore PK
    Methods Enzymol; 2015; 554():143-67. PubMed ID: 25725521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. H
    Yurinskaya MM; Krasnov GS; Kulikova DA; Zatsepina OG; Vinokurov MG; Chuvakova LN; Rezvykh AP; Funikov SY; Morozov AV; Evgen'ev MB
    Inflamm Res; 2020 May; 69(5):481-495. PubMed ID: 32157318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphinodithioate and Phosphoramidodithioate Hydrogen Sulfide Donors.
    Whiteman M; Perry A; Zhou Z; Bucci M; Papapetropoulos A; Cirino G; Wood ME
    Handb Exp Pharmacol; 2015; 230():337-63. PubMed ID: 26162843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utilizing hydrogen sulfide as a novel anti-cancer agent by targeting cancer glycolysis and pH imbalance.
    Lee ZW; Teo XY; Tay EY; Tan CH; Hagen T; Moore PK; Deng LW
    Br J Pharmacol; 2014 Sep; 171(18):4322-36. PubMed ID: 24827113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The route and timing of hydrogen sulfide therapy critically impacts intestinal recovery following ischemia and reperfusion injury.
    Jensen AR; Drucker NA; Te Winkel JP; Ferkowicz MJ; Markel TA
    J Pediatr Surg; 2018 Jun; 53(6):1111-1117. PubMed ID: 29622397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GYY4137 alleviates sepsis-induced acute lung injury in mice by inhibiting the PDGFRβ/Akt/NF-κB/NLRP3 pathway.
    Li J; Ma J; Li M; Tao J; Chen J; Yao C; Yao S
    Life Sci; 2021 Apr; 271():119192. PubMed ID: 33577850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of synthesized GYY4137, a slowly releasing hydrogen sulfide donor, on cell viability and distribution of hydrogen sulfide in mice].
    Yu F; Zhao J; Tang CS; Geng B
    Beijing Da Xue Xue Bao Yi Xue Ban; 2010 Oct; 42(5):493-7. PubMed ID: 20957002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening of a composite library of clinically used drugs and well-characterized pharmacological compounds for cystathionine β-synthase inhibition identifies benserazide as a drug potentially suitable for repurposing for the experimental therapy of colon cancer.
    Druzhyna N; Szczesny B; Olah G; Módis K; Asimakopoulou A; Pavlidou A; Szoleczky P; Gerö D; Yanagi K; Törö G; López-García I; Myrianthopoulos V; Mikros E; Zatarain JR; Chao C; Papapetropoulos A; Hellmich MR; Szabo C
    Pharmacol Res; 2016 Nov; 113(Pt A):18-37. PubMed ID: 27521834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydrogen Sulfide Donor GYY4137 Acts Through Endothelial Nitric Oxide to Protect Intestine in Murine Models of Necrotizing Enterocolitis and Intestinal Ischemia.
    Drucker NA; Jensen AR; Te Winkel JP; Markel TA
    J Surg Res; 2019 Feb; 234():294-302. PubMed ID: 30527488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GYY4137, an Extended-Release Hydrogen Sulfide Donor, Reduces NMDA-Induced Neuronal Injury in the Murine Retina.
    Sone K; Mori A; Sakamoto K; Nakahara T
    Biol Pharm Bull; 2018; 41(4):657-660. PubMed ID: 29607941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new slow releasing, H₂S generating compound, GYY4137 relaxes spontaneous and oxytocin-stimulated contractions of human and rat pregnant myometrium.
    Robinson H; Wray S
    PLoS One; 2012; 7(9):e46278. PubMed ID: 23029460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of hydrogen sulfide gas as a treatment against P. falciparum, murine cerebral malaria, and the importance of thiolation state in the development of cerebral malaria.
    DellaValle B; Staalsoe T; Kurtzhals JA; Hempel C
    PLoS One; 2013; 8(3):e59271. PubMed ID: 23555646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.